Dexamethasone in severe COVID-19 infection: A case series

Mohamed Eliwa Hassan; Hasan Msn Hasan; Kannan Sridharan; Adel Elkady; Mohamed Ma ElSeirafi

doi:10.1016/j.rmcr.2020.101205

Dexamethasone in severe COVID-19 infection: A case series

Respir Med Case Rep. 2020:31:101205. doi: 10.1016/j.rmcr.2020.101205. Epub 2020 Aug 28.

Authors

Mohamed Eliwa Hassan¹, Hasan Msn Hasan¹, Kannan Sridharan², Adel Elkady¹, Mohamed Ma ElSeirafi¹

Affiliations

¹ Intensive Care Unit, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain.
² Department of Pharmacology & Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.

Abstract

Evidence supporting the use of dexamethasone in severe COVID-19 patients is emerging. In this case series, we share our experience in using dexamethasone in five COVID-19 infected patients with acute respiratory distress syndrome.

Keywords: COVID-19; Coronavirus; Corticosteroids; Dexamethasone.

Publication types

Case Reports